Dynamics of thromboxane level changes during early phase of allograft reperfusion

被引:13
作者
Dolegowska, Barbara [3 ]
Blogowski, Wojciech [1 ]
Domanski, Leszek [2 ]
机构
[1] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, PL-70111 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Nephrol Transplantol & Internal Med, PL-70111 Szczecin, Poland
[3] Pomeranian Med Univ, Dept Med Chem & Biochem, PL-70111 Szczecin, Poland
关键词
delayed graft function; early allograft function; ischemia-reperfusion injury; kidney transplantation; thromboxane; DELAYED GRAFT FUNCTION; KIDNEY-TRANSPLANTS; RENAL-TRANSPLANTATION; MULTIVARIATE-ANALYSIS; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSES; MESANGIAL CELLS; REJECTION; INJURY; PROSTAGLANDINS;
D O I
10.1111/j.1399-0012.2009.00983.x
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: Thromboxane (Tx) is a metabolite of arachidonic acid, which exerts a significant influence on kidney homeostasis, and may be involved in the pathogenesis of allograft rejection. The aim of this study was to: examine the dynamics of TxB2 changes during early phase of kidney allograft reperfusion, and analyze whether the observed changes in the concentrations and direction of TxB2 changes, are associated with post-transplant graft function. Methods: Sixty-nine transplant recipients were divided into early, slow and delayed graft function group. Blood samples were collected directly before and during first the five minutes of allograft reperfusion. TxB2 concentrations were measured using ELISA. Creatinine and GFR levels were measured on the first, fifth, and 10th post-transplant day. Results: The results demonstrated that during reperfusion significant differences in TxB2 concentrations occur in all groups. Moreover, significant differences in the concentrations, as well as in the dynamics of TxB2 changes between patients with immediate graft function, and individuals with allograft activation problems, were noticed. These differences were associated with post-transplant graft function. Conclusions: Human renal transplantations are accompanied by changes in TxB2 concentrations, and the dynamics of TxB2 changes is associated with early post-transplant graft function. Our results also highlight TxB2 as a potential pre-transplant marker of post-transplant allograft function.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 31 条
[1]
RAT KIDNEY THROMBOXANE RECEPTOR - MOLECULAR-CLONING, SIGNAL-TRANSDUCTION, AND INTRARENAL EXPRESSION LOCALIZATION [J].
ABE, T ;
TAKEUCHI, K ;
TAKAHASHI, N ;
TSUTSUMI, E ;
TANIYAMA, Y ;
ABE, K .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :657-664
[2]
New horizons in prevention and treatment of ischaemic injury to kidney transplants [J].
Aydin, Zeynep ;
van Zonneveld, Anton J. ;
de Fijter, Johan W. ;
Rabelink, Ton J. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) :342-346
[3]
Cytosolic phospholipase A2 inhibition attenuates ischemia-reperfusion injury in an isolated rat lung model [J].
Bellido-Reyes, Yury A. ;
Akamatsu, Hideki ;
Kojima, Katsuo ;
Arai, Hirokuni ;
Tanaka, Hiroyuki ;
Sunamori, Makoto .
TRANSPLANTATION, 2006, 81 (12) :1700-1707
[4]
THROMBOXANE STIMULATES SYNTHESIS OF EXTRACELLULAR-MATRIX PROTEINS INVITRO [J].
BRUGGEMAN, LA ;
HORIGAN, EA ;
HORIKOSHI, S ;
RAY, PE ;
KLOTMAN, PE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (03) :F488-F494
[5]
Complement in renal transplantation [J].
Chowdhury, P ;
Zhou, W ;
Sacks, SH .
NEPHRON CLINICAL PRACTICE, 2003, 95 (01) :C3-C8
[6]
CHRONIC THROMBOXANE INHIBITION PRESERVES FUNCTION OF REJECTING RAT RENAL-ALLOGRAFTS [J].
COFFMAN, TM ;
RUIZ, P ;
SANFILIPPO, F ;
KLOTMAN, PE .
KIDNEY INTERNATIONAL, 1989, 35 (01) :24-30
[7]
Metabolism of eicosanoids and their action on renal function during ischaemia and reperfusion: The effect of alprostadil [J].
Dolegowska, B. ;
Pikula, E. ;
Safranow, K. ;
Olszewska, M. ;
Jakubowska, K. ;
Chlubek, D. ;
Gutowski, P. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2006, 75 (06) :403-411
[8]
DOLGOWSKA B, 2009, PRELIMINARY REPORT T, V22, P546
[9]
Activity of CuZn-superoxide dismutase, catalase and glutathione peroxidase in erythrocytes in kidney allografts during reperfusion in patients with and without delayed graft function [J].
Domanski, L ;
Dolegowska, B ;
Safranow, K ;
Rózanski, J ;
Myslak, M ;
Romanowski, M ;
Sienko, J ;
Sulikowski, T ;
Ostrowski, M ;
Kedzierska, K ;
Domanski, M ;
Chlubek, D ;
Pawlik, A ;
Ciechanowski, K .
CLINICAL TRANSPLANTATION, 2006, 20 (01) :67-71
[10]
THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES [J].
HAMBERG, M ;
SVENSSON, J ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :2994-2998